Novel tricyclic compounds are found to be useful for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling.
Tricyclic purine compounds and their analogs as inhibitors of cytokine signalling
申请人:CELL THERAPEUTICS, INC.
公开号:EP1690864A2
公开(公告)日:2006-08-16
Novel tricyclic compounds are found to be useful for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling.